These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 6292302)
1. Cytotoxicity by NK-like cells from hepatitis B-immune patients to a human hepatoma cell line secreting HBsAg. Chin TW; Hollinger FB; Rich RR; Troisi CL; Dreesman GR; Melnick JL J Immunol; 1983 Jan; 130(1):173-80. PubMed ID: 6292302 [No Abstract] [Full Text] [Related]
2. [The vaccine for hepatitis B virus. Definition of criteria for its use]. Sturm JA Rev Paul Med; 1985; 103(1):23-31. PubMed ID: 2994199 [No Abstract] [Full Text] [Related]
3. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226 [TBL] [Abstract][Full Text] [Related]
4. Recognition of hepatitis B surface antigen by the human hepatoma cell line HepG2. Kaiser J; Stockert RJ; Schein PS; Wolkoff AW Trans Assoc Am Physicians; 1986; 99():86-91. PubMed ID: 3037754 [No Abstract] [Full Text] [Related]
5. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus. Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149 [TBL] [Abstract][Full Text] [Related]
6. Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen. Gerber MA; Garfinkel E; Hirschman SZ; Thung SN; Panagiotatos T J Immunol; 1981 Mar; 126(3):1085-9. PubMed ID: 6161957 [TBL] [Abstract][Full Text] [Related]
7. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860 [TBL] [Abstract][Full Text] [Related]
8. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis. Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478 [TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161 [TBL] [Abstract][Full Text] [Related]
10. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma. Chen WN; Oon CJ Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398 [TBL] [Abstract][Full Text] [Related]
11. Purification of HBsAg produced by the human hepatoma cell line PLC/PRE/5 by affinity chromatography using monoclonal antibodies and application for ELISA diagnostic. Merten OW; Reiter S; Scheirer W; Katinger H Dev Biol Stand; 1983; 55():121-7. PubMed ID: 6329855 [TBL] [Abstract][Full Text] [Related]
12. Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5). Barin F; Goudeau A; Brechot C; Romet-Lemonne J; Sureau C; Lesage G Dev Biol Stand; 1983; 54():81-92. PubMed ID: 6317496 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore. Khin LW; Teo CJ; Guan R Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of HBsAg secretion from Alexander cell line by Phyllanthus amarus. Jayaram S; Thyagarajan SP Indian J Pathol Microbiol; 1996 Jul; 39(3):211-5. PubMed ID: 8972151 [TBL] [Abstract][Full Text] [Related]
15. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients. Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369 [TBL] [Abstract][Full Text] [Related]
16. Cellular immunity to the hepatitis B virion in acute hepatitis type B. Fattovich G; Alberti A; Crivellaro C; Pontisso P; Noventa F; Realdi G Clin Exp Immunol; 1983 Sep; 53(3):645-50. PubMed ID: 6616959 [TBL] [Abstract][Full Text] [Related]
17. The effect of glucocorticoid hormones on release of HBsAg from PLC/PRF/5 (Alexander) hepatoma cells. Marshall J; Coulepis A; Pringle R; Dimitrakakis M; Gust ID Acta Virol; 1983 Sep; 27(5):429-33. PubMed ID: 6139947 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases. Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559 [No Abstract] [Full Text] [Related]
19. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma. Lin X; Qian GS; Lu PX; Wu L; Wen YM J Med Virol; 2001 Jul; 64(3):299-304. PubMed ID: 11424118 [TBL] [Abstract][Full Text] [Related]
20. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein. Chisari FV; Bieber MS; Josepho CA; Xavier C; Anderson DS J Immunol; 1981 Jan; 126(1):45-9. PubMed ID: 6450241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]